AMZ002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AMZ002, covering 2023-04-20 to 2023-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety and Efficacy of AMZ002 Treatment, Compared With Vigabatrin in Participants With Infantile Spasms [Phase 3]